Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

349 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of experimental hyperglycaemia on renal haemodynamics in prediabetic patients with and without AT1 receptor blockade.
Frank H, Pscherer S, Fliser D, Heemann U. Frank H, et al. Among authors: fliser d. Eur J Clin Invest. 2010 May;40(5):414-21. doi: 10.1111/j.1365-2362.2010.02284.x. Eur J Clin Invest. 2010. PMID: 20534063
Circulating angiopoietin-2 levels increase with progress of chronic kidney disease.
David S, Kümpers P, Lukasz A, Fliser D, Martens-Lobenhoffer J, Bode-Böger SM, Kliem V, Haller H, Kielstein JT. David S, et al. Among authors: fliser d. Nephrol Dial Transplant. 2010 Aug;25(8):2571-6. doi: 10.1093/ndt/gfq060. Epub 2010 Feb 22. Nephrol Dial Transplant. 2010. PMID: 20179005
Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrolled trial.
Krebs S, Omer B, Omer TN, Fliser D. Krebs S, et al. Among authors: fliser d. Am J Kidney Dis. 2010 Dec;56(6):1095-9. doi: 10.1053/j.ajkd.2010.06.025. Epub 2010 Sep 16. Am J Kidney Dis. 2010. PMID: 20843592 Clinical Trial.
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.
Zewinger S, Kleber ME, Rohrer L, Lehmann M, Triem S, Jennings RT, Petrakis I, Dressel A, Lepper PM, Scharnagl H, Ritsch A, Thorand B, Heier M, Meisinger C, de Las Heras Gala T, Koenig W, Wagenpfeil S, Schwedhelm E, Böger RH, Laufs U, von Eckardstein A, Landmesser U, Lüscher TF, Fliser D, März W, Meinitzer A, Speer T. Zewinger S, et al. Among authors: fliser d. Eur Heart J. 2017 May 21;38(20):1597-1607. doi: 10.1093/eurheartj/ehx118. Eur Heart J. 2017. PMID: 28379378
Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.
Lorenzen J, Krämer R, Kliem V, Bode-Boeger SM, Veldink H, Haller H, Fliser D, Kielstein JT. Lorenzen J, et al. Among authors: fliser d. Eur J Clin Invest. 2010 Apr;40(4):294-300. doi: 10.1111/j.1365-2362.2010.02271.x. Eur J Clin Invest. 2010. PMID: 20486990
Erythropoietin and the endothelium - a promising link?
Fliser D, Bahlmann FH. Fliser D, et al. Eur J Clin Invest. 2008 Jul;38(7):457-61. doi: 10.1111/j.1365-2362.2008.01968.x. Epub 2008 May 21. Eur J Clin Invest. 2008. PMID: 18505404 Review.
Chronic erythropoietin treatment affects different molecular pathways of diabetic cardiomyopathy in mouse.
Shushakova N, Park JK, Menne J, Fliser D. Shushakova N, et al. Among authors: fliser d. Eur J Clin Invest. 2009 Sep;39(9):755-60. doi: 10.1111/j.1365-2362.2009.02165.x. Epub 2009 Jul 14. Eur J Clin Invest. 2009. PMID: 19614950
Effective achievement of hemoglobin stability with once-monthly C.E.R.A. in peritoneal dialysis patients: a prospective study.
Koch M, Treiber W, Fliser D. Koch M, et al. Among authors: fliser d. Clin Drug Investig. 2013 Oct;33(10):699-706. doi: 10.1007/s40261-013-0091-z. Clin Drug Investig. 2013. PMID: 23975657 Free PMC article.
Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure.
Kielstein JT, Bode-Böger SM, Klein G, Graf S, Haller H, Fliser D. Kielstein JT, et al. Among authors: fliser d. Eur J Clin Invest. 2003 May;33(5):370-5. doi: 10.1046/j.1365-2362.2003.01149.x. Eur J Clin Invest. 2003. PMID: 12713449
Opposing effects of angiotensin II on muscle and renal blood flow under euglycemic conditions.
Fliser D, Dikow R, Demukaj S, Ritz E. Fliser D, et al. J Am Soc Nephrol. 2000 Nov;11(11):2001-6. J Am Soc Nephrol. 2000. PMID: 11053475 Clinical Trial.
349 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page